Search Results - "Hagen, F."

Preoperative Treatment of Locally Advanced Rectal Cancer by Schrag, Deborah, Shi, Qian, Weiser, Martin R., Gollub, Marc J., Saltz, Leonard B., Musher, Benjamin L., Goldberg, Joel, Al Baghdadi, Tareq, Goodman, Karyn A., McWilliams, Robert R., Farma, Jeffrey M., George, Thomas J., Kennecke, Hagen F., Shergill, Ardaman, Montemurro, Michael, Nelson, Garth D., Colgrove, Brian, Gordon, Vallerie, Venook, Alan P., O’Reilly, Eileen M., Meyerhardt, Jeffrey A., Dueck, Amylou C., Basch, Ethan, Chang, George J., Mamon, Harvey J.

“…In a trial comparing preoperative chemoradiotherapy and FOLFOX in patients with rectal cancer undergoing sphincter-sparing surgery, 5-year disease-free…”
Get full text

Endovascular Treatment of Unruptured MCA Bifurcation Aneurysms Regardless of Aneurysm Morphology: Short- and Long-Term Follow-Up by Hagen, F, Maurer, C J, Berlis, A

“…The optimal treatment of unruptured middle cerebral aneurysms is still under debate. Although today almost any aneurysm can be treated endovascularly, there is…”
Get full text

Adjuvant chemotherapy use and outcomes of patients with high‐risk versus low‐risk stage II colon cancer by Kumar, Aalok, Kennecke, Hagen F., Renouf, Daniel J., Lim, Howard J., Gill, Sharlene, Woods, Ryan, Speers, Caroline, Cheung, Winson Y.

“…BACKGROUND Adjuvant chemotherapy (AC) is frequently considered in patients with stage II colon cancer who are considered to be at high risk. However, to the…”
Get full text

Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study by Chen, Eric X, Jonker, Derek J, Loree, Jonathan M, Kennecke, Hagen F, Berry, Scott R, Couture, Felix, Ahmad, Chaudhary E, Goffin, John R, Kavan, Petr, Harb, Mohammed, Colwell, Bruce, Samimi, Setareh, Samson, Benoit, Abbas, Tahir, Aucoin, Nathalie, Aubin, Francine, Koski, Sheryl L, Wei, Alice C, Magoski, Nadine M, Tu, Dongsheng, O'Callaghan, Chris J

“…Single-agent immune checkpoint inhibition has not shown activities in advanced refractory colorectal cancer (CRC), other than in those patients who are…”
Get more information

Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer by Topham, James T, O'Callaghan, Chris J, Feilotter, Harriet, Kennecke, Hagen F, Lee, Young S, Li, Weimin, Banks, Kimberly C, Quinn, Katie, Renouf, Daniel J, Jonker, Derek J, Tu, Dongsheng, Chen, Eric X, Loree, Jonathan M

“…Anti-epidermal growth factor receptor (EGFR) antibodies are effective treatments for metastatic colorectal cancer. Improved understanding of acquired…”
Get full text

Multidrug-resistant endemic clonal strain of Candida auris in India by Chowdhary, A., Anil Kumar, V., Sharma, C., Prakash, A., Agarwal, K., Babu, R., Dinesh, K. R., Karim, S., Singh, S. K., Hagen, F., Meis, J. F.

“…Candida auris is a recently described rare agent of fungemia. It is notable for its antifungal resistance. A total of 15 C. auris isolates, originating from…”
Get full text

Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism by Prakash, A., Sharma, C., Singh, A., Kumar Singh, P., Kumar, A., Hagen, F., Govender, N.P., Colombo, A.L., Meis, J.F., Chowdhary, A.

“…Candida auris is a multidrug-resistant nosocomial bloodstream pathogen that has been reported from Asian countries and South Africa. Herein, we studied the…”
Get full text

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole by Espinel-Ingroff, A, Aller, A I, Canton, E, Castañón-Olivares, L R, Chowdhary, A, Cordoba, S, Cuenca-Estrella, M, Fothergill, A, Fuller, J, Govender, N, Hagen, F, Illnait-Zaragozi, M T, Johnson, E, Kidd, S, Lass-Flörl, C, Lockhart, S R, Martins, M A, Meis, J F, Melhem, M S C, Ostrosky-Zeichner, L, Pelaez, T, Pfaller, M A, Schell, W A, St-Germain, G, Trilles, L, Turnidge, J

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Stability of Retained Inferior Vena Cava Filter Fragments after Filter Removal by Puller, Hagen F., Stavropoulos, S. William, Trerotola, Scott O.

“…To assess the stability and outcome of fractured inferior vena cava (IVC) filter fragments that are retained in patients after IVC filter removal. A…”
Get full text

Recent trends in molecular diagnostics of yeast infections: from PCR to NGS by Opathy, Consortium, Gabaldon, Toni

“…The incidence of opportunistic yeast infections in humans has been increasing over recent years. These infections are difficult to treat and diagnose, in part…”
Get full text

Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix by Tsang, Erica S., McConnell, Yarrow J., Schaeffer, David F., Lee, Lawrence, Yin, Yaling, Zerhouni, Siham, Schaff, Kimberly, Speers, Caroline, Kennecke, Hagen F.

“…Background Goblet cell carcinoids (GCCs) of the appendix are rare mucinous neoplasms, for which optimal therapy is poorly described. We examined prognostic…”
Get full text

Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results by Kennecke, Hagen F, O'Callaghan, Chris J, Loree, Jonathan M, Moloo, Hussein, Auer, Rebecca, Jonker, Derek J, Raval, Manoj, Musselman, Reilly, Ma, Grace, Caycedo-Marulanda, Antonio, Simianu, Vlad V, Patel, Sunil, Pitre, Lacey D, Helewa, Ramzi, Gordon, Vallerie L, Neumann, Katerina, Nimeiri, Halla, Sherry, Max, Tu, Dongsheng, Brown, Carl J

“…Organ-sparing therapy for early-stage I/IIA rectal cancer is intended to avoid functional disturbances or a permanent ostomy associated with total mesorectal…”
Get full text

Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports by Zhang, Hagen, Stielow, Rodrigues, Samerpitak, Zhou, Feng, Yang, Chen, Deng, Li, Liao, Li, Li, Meis, Guarro, Teixeira, Al-Zahrani, de Camargo, Z. Pires, Zhang, de Hoog

“…Pathology to vertebrate hosts has emerged repeatedly in the order Ophiostomatales. Occasional infections have been observed in Sporothrix mexicana at a low…”
Get full text

The interaction between SPARC and GRP78 interferes with ER stress signaling and potentiates apoptosis via PERK/eIF2α and IRE1α/XBP-1 in colorectal cancer by Chern, Yi-Jye, Wong, John C. T., Cheng, Grace S. W., Yu, Angel, Yin, Yaling, Schaeffer, David F., Kennecke, Hagen F., Morin, Gregg, Tai, Isabella T.

“…Therapy-refractory disease is one of the main contributors of treatment failure in cancer. In colorectal cancer (CRC), SPARC can function as a sensitizer to…”
Get full text

The utility of abbreviated patient‐reported outcomes for predicting survival in early stage colorectal cancer by Hsu, Tina, Speers, Caroline H., Kennecke, Hagen F., Cheung, Winson Y.

“…BACKGROUND Patient‐reported outcomes (PROs) are increasingly used in clinical settings. Prior research suggests that PROs collected at baseline may be…”
Get full text

Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care by Del Rivero, Jaydira, Mailman, Josh, Rabow, Michael W, Chan, Jennifer A, Creed, Sarah, Kennecke, Hagen F, Pasieka, Janice, Zuar, Jennifer, Singh, Simron, Fishbein, Lauren

“…This serves as a white paper by the North American Neuroendocrine Tumor Society (NANETS) on the practical considerations when providing palliative care to…”
Get full text

Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial by Loree, Jonathan M, Titmuss, Emma, Topham, James T, Kennecke, Hagen F, Feilotter, Harriet, Virk, Shakeel, Lee, Young S, Banks, Kimberly, Quinn, Katie, Karsan, Aly, Renouf, Daniel J, Jonker, Derek J, Tu, Dongsheng, O'Callaghan, Chris J, Chen, Eric X

“…Tissue-derived tumor mutation burden (TMB) of ≥10 mutations/Mb is a histology-agnostic biomarker for the immune checkpoint inhibitor (ICI) pembrolizumab…”
Get full text

A Rare Genotype of Cryptococcus gattii Caused the Cryptococcosis Outbreak on Vancouver Island (British Columbia, Canada) by Kidd, S. E., Hagen, F., Tscharke, R. L., Huynh, M., Bartlett, K. H., Fyfe, M., MacDougall, L., Boekhout, T., Kwon-Chung, K. J., Meyer, W., Colwell, Rita R.

“…Cryptococcus gattii causes life-threatening infection of the pulmonary and central nervous systems in hosts with normal immunity and traditionally has been…”
Get full text

Retinoic acid signaling regulates spatiotemporal specification of human green and red cones by Hadyniak, Sarah E, Hagen, Joanna F D, Eldred, Kiara C, Brenerman, Boris, Hussey, Katarzyna A, McCoy, Rajiv C, Sauria, Michael E G, Kuchenbecker, James A, Reh, Thomas, Glass, Ian, Neitz, Maureen, Neitz, Jay, Taylor, James, Johnston, Jr, Robert J

“…Trichromacy is unique to primates among placental mammals, enabled by blue (short/S), green (medium/M), and red (long/L) cones. In humans, great apes, and Old…”
Get full text

High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients by Fuhren, J, Voskuil, W S, Boel, C H E, Haas, P J A, Hagen, F, Meis, J F, Kusters, J G

“…Aspergillus fumigatus is the leading cause of invasive aspergillosis. Adequate treatment is complicated by an increase in azole resistance. Here, the incidence…”
Get full text